Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Tobramycin for CF patients with P. aeruginosa infection

    • 7 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Tobramycin for CF patients with P. aeruginosa infection. Pharmacoecon. Outcomes News 253, 7 (2000). https://doi.org/10.1007/BF03266942

    Download citation

    Keywords

    • Cystic Fibrosis
    • Pseudomonas Aeruginosa
    • Tobramycin
    • Cystic Fibrosis Patient
    • Direct Medical Cost